PRO MEDICUS LIMITED — Director's Dealing 2014

Dec 17, 2014

Appendix 3Y Change of Director’s Interest Notice

Listing Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/9/2001.

Name of entity Pro Medicus Limited ABN 25 006 194 752

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of DirectorDate of last notice	Anthony Barry HALL8 December 2014

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interestNature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest.Date of changeNo. of securities held prior to changeClassNumber acquiredNumber disposedValue/ConsiderationNote: If consideration is non-cash, provide details and estimated valuation

IndirectOrdinary fully paid shares in Pro MedicusLimited held by the Akay SuperannuationFund of which the Director is a Trustee andMember15 December 201430,067,500 ordinary shares consisting off:-30,000,000 ordinary shares heldunder Anthony Barry HALL67,500 ordinary shares held underAkay Superannuation FundOrdinary sharesOff market transfer of 300,000 from AnthonyBarry HALL to Akay Superannuation FundNil$1.05 cents per share

• See chapter 19 for defined terms.

Appendix 3Y Page 1

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change	30,067,500 ordinary shares consisting off:-29,700,000 ordinary shares heldunder Anthony Barry HALL367,500 ordinary shares held underAkay Superannuation Fund
Nature of changeExample: on-market trade, off-market trade, exercise of options, issue ofsecurities under dividend reinvestment plan, participation in buy-back	Off market transfer

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest	N/A
Name of registered holder(if issued securities)	N/A
Date of change	N/A
No. and class of securities to whichinterest related prior to changeNote: Details are only required for a contract in relationto which the interest has changed	N/A
Interest acquired	N/A
Interest disposed	N/A
Value/ConsiderationNote: If consideration is non-cash, provide details and anestimated valuation	N/A
Interest after change	N/A

Part 3 –[+] Closed period

Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required?	No
If so, was prior written clearance provided to allow thetrade to proceed during this period?	N/A
If prior written clearance was provided, on what date wasthis provided?	N/A

• See chapter 19 for defined terms.

Appendix 3Y Page 2

11/3/2002

Appendix 3Y Change of Director’s Interest Notice

For and on behalf of Pro Medicus Limited

==> picture [133 x 63] intentionally omitted <==

Clayton Hatch Company Secretary 18 December 2014

• See chapter 19 for defined terms.

Appendix 3Y Page 3

11/3/2002